Patent · US Active

SirT inhibitors that bind to NAD

US8486990B2 · kind B2 · utility

7Cited by

5References

5Claims

0Family size

Assignee

ELIXIR PHARMACEUTICALS, INC. · US

Inventors

Andrew Napper · Salem, US
Peter Distefano · Upton, US
Rory Curtis · Southborough, US
Jeffrey Hixon · Salisbury, US
Thomas McDonagh · Boston, US
L. Julie Huber · Newton, US
Jonathan M. Solomon · Somerville, US
Russell Thomas · Verona, IT
Jean-Francois Pons · Shrivenham, GB

Key dates

Filing date	Apr 14, 2009
Grant date	Jul 16, 2013
Priority date	—
Expiry date	Jun 21, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compound of formula (I)and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.